Literature DB >> 12664908

How will we regulate genetic enhancement?

M J Mehlman1.   

Abstract

Genetic enhancement technologies present difficult and novel regulatory issues, including the problem of measuring and comparing risks and benefits and dealing with the impact of these technologies on social values. This Article describes and evaluates the potential approaches that may be taken to regulate these technologies. The author concludes that a variety of approaches will be necessary, involving self-regulation, government restrictions on access and use, licensing, and a national lottery.

Keywords:  Biomedical and Behavioral Research; Genetics and Reproduction; Legal Approach

Mesh:

Substances:

Year:  1999        PMID: 12664908

Source DB:  PubMed          Journal:  Wake Forest Law Rev        ISSN: 0043-003X


  5 in total

Review 1.  On the possibility and desirability of constructing a neutral conception of disability.

Authors:  Anita Silvers
Journal:  Theor Med Bioeth       Date:  2003

2.  Cognition-enhancing drugs.

Authors:  Maxwell J Mehlman
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 3.  Ethics in nanomedicine.

Authors:  David B Resnik; Sally S Tinkle
Journal:  Nanomedicine (Lond)       Date:  2007-06       Impact factor: 5.307

4.  Disease Resistance and the Definition of Genetic Enhancement.

Authors:  Derek So; Erika Kleiderman; Seydina B Touré; Yann Joly
Journal:  Front Genet       Date:  2017-04-10       Impact factor: 4.599

5.  From goodness to good looks: Changing images of human germline genetic modification.

Authors:  Derek So
Journal:  Bioethics       Date:  2021-07-03       Impact factor: 2.512

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.